lacosamide
Commercial- Indications
- focal seizures, generalized tonic-clonic seizure
Company intelligence / Profile preview
Research Corporation Technologies provides early-stage funding, strategic guidance, licensing support, and commercialization expertise to biomedical innovations—especially those originating from academic research. It has played a role in the development/commercialization of major therapeutics such as cisplatin, carboplatin, GM-CSF biologics, technetium imaging agents, PSA blood test for prostate cancer diagnostics, Vimpat® for epilepsy/seizures treatment. Its current activities center around venture investment in biotech startups/platforms across therapeutics modalities including biologics/proteins/exosomes/nanoparticles/small molecules.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Research Corporation Technologies.